|
Published by: Kalorama Information
Published: Apr. 1, 2007 - 68 Pages
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Market Analysis
- Competitive Analysis
- Scope and Methodology
CHAPTER TWO: OVERVIEW
- Nicotine Addiction
- Drug Dependence
- Issues, Trends and Developments
- Cost Effectiveness of Smoking Cessation
- Therapeutic Benefits
- Importance of Physician Intervention
- Alternative Therapies
- Cautious Optimism for Lower U.S. Smoking
- Genetic Risk Factors for Smoking and Drug Addiction
- Incentive Based Treatments for Drug Abuse
- Reimbursement
- Description of Current Products
- Smoking Cessation
- Chantix/Champix
- Zyban
- Accomplia
- Nicotrol
- Alcohol and Opiate Dependence and Related
- Subutex
- Campral
- Methodone
- ReVia/Naltrex
- Antabuse
- Narcan
- Vivitrol
- Depade
- Research and Development
- Acomplia
- Lofexidine
- Naltrexone Depot
- Lybrel
- SSR591813
- Cyt002-NicQb
- NicVAX
CHAPTER THREE: MARKET DATA AND ANALYSIS
- Markets by Geographical Segments
- U.S. Market
- European Union Market
- Japan and ROW Market
- Market Data by Indication
- Competitive Analysis
CHAPTER FOUR: Company Profiles
- Barr Laboratories, Inc
- Bristol-Myers Squibb
- Cephalon, Inc
- Forest Laboratories, Inc
- GlaxoSmithKline PLC
- Pfizer, Inc
- Sanofi-Aventis
TABLE of EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Exhibit 1: Cost of Smoking, Drug Abuse and Alchohol Addiction Worldwide
- Exhibit 2: Smoking Cessation & Addiction Treatment Market
- Exhibit 3: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Market Share, Estimated 2005
CHAPTER TWO: OVERVIEW
- Exhibit 4: Estimated World Prevalence of Conditions
- Exhibit 5: Economic Cost of Smoking-Related Illness
- Exhibit 6: Cost of Drug Addiction International and US
- Exhibit 7: Benefits of Smoking Cessation
- Exhibit 8: Recent Smoking Cessation and Addiction Treatment Approvals
- Exhibit 9: Research and Development: Smoking Cessation and Addiction Treatments
CHAPTER THREE: MARKET DATA AND ANALYSIS
- Exhibit 10: Smoking Cessation & Addiction Treatment: Worldwide Market
- Exhibit 11: World Smoking Cessation & Addiction Treatment Market
- Exhibit 12: World Market: Smoking Cessation and Addiction Treatment Market by Geographical Segment 2003-2010
- Exhibit 13: World Market Smoking Cessation and Addiction Treatment Market by Geographical Segment, 2003-2010
- Exhibit 14: World Market: Smoking Cessation and Addiction Treatment Market by Geographical Segment - Percent Distribution, 2003-2010
- Exhibit 15: World Market: Smoking Cessation and Addiction Treatment Market by Geographical Segment and Percent Market Share, 2005
- Exhibit 16: World Market Smoking Cessation and Addiction Treatment Market by Geographical Segment and Percent Market Share, 2010
- Exhibit 17: Estimated Smoking Cessation and Addiction Treatment Sales by Indication, 2005
- Exhibit 18 Drug Sales by Indication, 2005
- Exhibit 19: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Shares by Market Revenues Estimated 2005 and Projected 2010
- Exhibit 20: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Market Share, Estimated 2005
- Exhibit 21: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Market Share, Projected 2010
- Exhibit 22: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Shares by Market Revenues Estimated 2005 and Projected 2010
- Exhibit 23: Smoking Cessation and Addiction Treatment Market Top Drugs by Estimated Sales and Percent of Market, 2005
- Exhibit 24: Smoking Cessation and Addiction Treatment Market Top Drugs by Estimated Sales and Percent of Market, 2010
AbstractSMOKING CESSATION IS AN increasingly important area of focus for pharmaceutical companies, healthcare entities and governments. There are 1.4 billion smokers in the world, and smoking is a known cause of heart disease, lung cancer, respiratory infections and many other diseases. This has created a large market for smoking cessation aids. The market, which Zyban currently holds a tenuous lock on, is about to change, with a major new brand ready to shake up the current market share. At the same time, the high incidence of smoking and strong public-sector motivation to reduce smoking signals room for new entrants.
The market for treatments for alcohol and drug abuse, now dominated by Subutex and Campral, will also see growth and a robust line of new products. Kalorama's Smoking Cessation and Addiction Treatments: A World Market Analysis covers the market for pharmaceuticals that assist with smoking cessation and addiction treatment.
Using information gathered for Kalorama's larger report on Psychotherapeutics: the World Market and interviews with psychotherapeutic industry insiders therein, this report takes a more detailed look at the combined market for both smoking cessation and alcohol/drug addiction treatments. The report includes:
- Round-up of current products available.
- Market share of major players and brands.
- Forecasted revenues to 2010.
- Forecasted Market Share with consideration of new players.
- Current revenues for 2005.
- World incidence data for Nicotine Addiction, Drug Addiction and Alcohol Abuse.
- Reviews of new products in the pipeline.
- Key trends driving pharmaceutical treatments for smoking cessation and drug addiction.
Product managers, business development executives, marketing managers, as well as executives in financial and advertising companies, are among those who will find this report a useful resource.
Get Full Details About This Report >>
|
